Colorectal Cancer Drugs Market Research Report, Share, and Forecast to 2025

Posted by rekha on October 11th, 2019

 The global colorectal cancer drugs market accounted for US$ XX Mn in 2018 and burgeoning over the forthcoming years. Some of the major factors influencing the market growth include rise in number of pipeline products, growing geriatric population worldwide coupled with increasing colorectal cancer cases, rise in healthcare expenditure worldwide and technological advancements in radiology and chemotherapy. However, side effects associated with drugs and high cost of the drugs are the factors hampering the market.

Global colorectal cancer drugs market segmented on the basis of therapy, drug type, distribution channel and region.

 For request sample:

Adjuvant Chemotherapy dominate the Global Colorectal Cancer Drugs Market

 Based on therapy, global colorectal cancer drugs market is segmented intoadjuvant chemotherapy, palliative chemotherapy, immuno therapy and neo adjuvant chemotherapy.Adjuvant Chemotherapy held considerable market share during the predicted period. Adjuvant chemotherapy is a method to fight cancer that joins diverse forms of healing. Adjuvant chemotherapy purposes to terminate hidden cancer cells that remain but are invisible. Chemotherapy and radiation, or chemotherapy and surgery are used collectively. Typically chemotherapy will be used after all of the known and visible cancer has been removed surgically or with radiation.

Asia Pacific Leads the Global Colorectal Cancer Drugs market

 PBI’s global colorectal cancer drugs market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis.Asia Pacific accounted for larger revenue share in global colorectal cancer drugs market with considerable CAGR. The growth in be in this region can be attributed to increase in R&D investments and rise in cancer awareness across the region. Also, the region is likely to provide huge growth opportunity for the market. Japan is the major contributor for the growth of the market in this region. In addition, North America held significant market share during the predicted period.

Strategic Approvals are the Key Strategies Adopted by Market Players

 Global colorectal cancer drugs market further reveals that the key players increasingly adopting strategies such as strategic approvals, launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For Instance, In Aug 2016, Sanofi’s Zaltrap received U.S. FDA approval to use with FOLFIRI to treat adult patients having colorectal cancer

Key player’s profiles in the report are Amgen Inc. (U.S), Bristol-Myers Squibb Company (U.S.), Hoffmann-La Roche Ltd. (Switzerland), Bayer AG (Germany), Merck & Co., Inc. (U.S.) and Sanofi (France).

Precision Business Insights (PBI) in its report titled “Global Colorectal Cancer Drugs Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Moreover, the report also includes the total revenue and volume for the market.

Detailed Segmentation


By Therapy    

o     Adjuvant Chemotherapy

o     Palliative Chemotherapy

o     Immuno Therapy

o     Neo Adjuvant Chemotherapy

By Drug Type

o     Capecitabine

o     Irinotecan

o     Fluorouracil

o     Trifluridine/tipiracil

o     Oxaliplatin

o     Others

By Distribution Channel        

o     Retail Pharmacies

o     Hospital Pharmacies

o     Online Pharmacies

By Geography

o     North America

  • U.S
  • Canada

o     Europe

  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

o     Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

o     Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

o     Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

For more information:

Like it? Share it!


About the Author

Joined: July 26th, 2019
Articles Posted: 219

More by this author